We read with great interest the GRECCAR 2 trial by Eric Rullier and colleagues (July 29, 2017, p 469),¹ which reported that local excision showed no superiority over total mesorectal excision in rectal cancer patients with a good response after chemoradiotherapy. However, some aspects of the study warrant closer attention.

中文翻译：

---

GRECCAR2试用版：细节值得更多关注

我们非常有兴趣地阅读了Eric Rullier及其同事进行的GRECCAR 2试验（2017年7月29日，第469页），¹该研究报道了局部放疗对直肠癌患者的总直肠系膜切除没有优势，在放化疗后反应良好。但是，该研究的某些方面值得进一步关注。